Jiangsu Hengrui Pharmaceuticals(600276) Stock Price Today

CN Stock MarketDetailed Quotes

600276 Jiangsu Hengrui Pharmaceuticals

Watchlist

49.97
-0.30-0.60%

Not Open Apr 28 15:00 CST

318.76BMarket Cap46.57P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | China's Securities Regulator Issues Filing Notice of Jiangsu Hengrui Pharmaceuticals' Hong Kong Listing Proposal
ReutersApr 28 07:27 ET
Hengrui Medicine's Unit Gets Nod to Trial Melanoma Drug
MT NewswiresApr 28 02:49 ET
Express News | Jiangsu Hengrui Pharmaceuticals Says Co Plans to Issue 815.09 Mln H-Shares for Hong Kong Listing
ReutersApr 27 20:47 ET
Jiangsu Hengrui Medicine Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Simply Wall StApr 26 20:53 ET
Do Its Financials Have Any Role To Play In Driving Jiangsu Hengrui Medicine Co., Ltd.'s (SHSE:600276) Stock Up Recently?
Simply Wall StApr 25 18:40 ET
Hengrui Pharmaceutical: Hengrui Pharmaceutical Report for the First Quarter of 2025
SZSIApr 24 12:00 ET · Announcements

Comments

Moomoo AI

Mar 2, 2024 07:44

The decline in EPS has likely disappointed the market, making investors hesitant to buy. Despite the recent share price increase, the long-term performance has been less impressive, significantly under-performing the market.

Shareholders in Jiangsu Hengrui Medicine (SHSE:600276) Are in the Red If They Invested Three Years Ago

Moomoo AI

Feb 13, 2024 08:50

Jiangsu Hengrui Medicine's high P/E ratio is backed by its promising earnings outlook. Investors retain the stock, expecting a bright future. The risk of earnings decline is not seen as substantial enough to justify a lower P/E ratio, bolstering the share price.